# Arixtra

NDC: 67457-594
Generic name: fondaparinux sodium
Labeler / Manufacturer: Mylan Institutional LLC
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: New Drug Application (innovator)
Dosage form: INJECTION, SOLUTION
Routes: SUBCUTANEOUS
Marketing started: 20140519

FDA application: NDA021345

## Active ingredients

- FONDAPARINUX SODIUM: 7.5 mg/.6mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"67457-594"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=67457-594
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=d3b30c68-cf45-4b46-8ba6-72090f7ba01a